← Eichor
Study identifier: NCT05340023 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension

Condition: Chronic Thromboembolic Pulmonary Hypertension  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH) is a rare but severe complication of pulmonary embolism (PE). CTEPH is evoked in patients with persistent dyspnea. According to international guidelines, symptomatic patients with perfusion defects on lung scan and Pulmonary Hypertension (PH)-likely transthoracic echo (TTE) must be evaluated in Pulmonary Hypertension (PH)-centers with right heart catheterism, to confirm or rule out the presence of precapillary Pulmonary Hypertension (PH), and precise the group of Pulmonary Hypertension (PH).

This description comes directly from the study's public registry record.

Talk to the study team

Laurent BERTOLETTI, MD PhD  ·  (0)477127770  ·  laurent.bertoletti@chu-st-etienne.fr

Carine LABRUYERE  ·  (0)477120826  ·  carine.labruyere@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de SAINT-ETIENNESaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05340023